Insulin Management in Gestational Diabetes
For gestational diabetes requiring pharmacologic therapy, initiate human insulin (NPH with regular insulin) or rapid-acting insulin analogues (lispro or aspart) combined with intermediate or long-acting basal insulin, starting at 0.5 units/kg/day based on current body weight, divided as 50% basal and 50% prandial insulin distributed across three meals. 1
Preferred Insulin Types
First-Line Rapid-Acting Insulins
- Insulin lispro and insulin aspart (both FDA Category B) are the preferred rapid-acting insulins for gestational diabetes, as they have been studied in randomized controlled trials and demonstrate safety in pregnancy 1
- These rapid-acting analogues provide better postprandial glycemic control and reduced hypoglycemia risk compared to regular human insulin 2, 3
First-Line Basal Insulins
- Insulin detemir (FDA Category B) and NPH insulin are the preferred long-acting options for basal coverage 1
- Insulin detemir has demonstrated improved fasting plasma glucose without increased hypoglycemia in head-to-head trials against NPH 3
- NPH insulin remains an acceptable alternative, particularly in resource-limited settings or when cost is a concern 1
Alternative Basal Insulin
- Insulin glargine (FDA Category C) can be considered acceptable despite limited randomized trial data, particularly for women already well-controlled on this regimen pre-pregnancy 1
- Observational studies suggest comparable safety to NPH insulin, though it should not be first-line 4
- Insulin degludec has been studied in pregnancy with no clear evidence of maternal or fetal harm, though data remain limited 5
Initial Dosing Strategy
Starting Dose Calculation
- Calculate total daily insulin dose as 0.5 units/kg/day based on current body weight 1
- Divide as 50% basal insulin (given once or twice daily) and 50% prandial insulin distributed across three meals 1
- For example, a 70 kg woman would start with 35 units total daily: 17.5 units basal + 17.5 units prandial (approximately 6 units before each meal) 1
Delivery Methods
- Both multiple daily injections (basal-bolus regimen) and continuous subcutaneous insulin infusion (pump therapy) are equally acceptable, with neither shown to be superior 4, 1
Titration and Monitoring Requirements
Glucose Targets
- Fasting glucose: 70-95 mg/dL (3.9-5.3 mmol/L) 6, 4
- One-hour postprandial: 110-140 mg/dL (6.1-7.8 mmol/L) 6, 4
- Two-hour postprandial: 100-120 mg/dL (5.6-6.7 mmol/L) 6, 4
Monitoring Frequency
- Perform blood glucose monitoring 4-6 times daily (fasting and postprandial) to guide insulin dose adjustments 4
- Monitor A1C monthly with a target <6% (42 mmol/mol) if achievable without significant hypoglycemia, or <7% (53 mmol/mol) if needed to prevent hypoglycemia 6
Dose Adjustment Timeline
- Evaluate and adjust insulin requirements every 2-3 weeks as pregnancy progresses 4
- Insulin requirements typically remain stable or decrease in the first trimester due to enhanced insulin sensitivity 6, 4
- Beginning around 16 weeks, insulin resistance increases exponentially, requiring dose increases of approximately 5% per week through week 36 6
- Total daily insulin requirements typically double to triple by the third trimester compared to initial doses 4
Critical Clinical Pitfalls
Warning Signs
- A rapid reduction in insulin requirements may indicate placental insufficiency and requires immediate obstetric evaluation 6, 4
- Pregnancy is a ketogenic state, and diabetic ketoacidosis can occur at lower glucose thresholds than in non-pregnant individuals 4
Hypoglycemia Management
- Provide comprehensive education on hypoglycemia prevention, recognition, and treatment to patients and family members before initiating insulin 4, 7
- Enhanced insulin sensitivity in early pregnancy increases hypoglycemia risk, particularly in the first trimester 6, 4
Nutritional Coordination
- Refer to a registered dietitian nutritionist to establish a meal plan, determine insulin-to-carbohydrate ratios, and set appropriate weight gain goals 6, 7
- Consistent carbohydrate intake at meals is essential to match insulin dosing and prevent glucose fluctuations 6, 7
Postpartum Considerations
- Insulin requirements drop precipitously after placental delivery 4
- Resume insulin at either 80% of pre-pregnancy doses or 50% of end-of-pregnancy doses immediately postpartum 4
- Close monitoring is required in the immediate postpartum period to prevent hypoglycemia 7
Specialized Care Recommendation
Due to the complexity of insulin management in pregnancy, referral to a specialized diabetes and pregnancy center offering team-based care is strongly recommended for optimal maternal and fetal outcomes 4, 7